Recombinant KIR2DL2 (Lirilumab Biosimilar) antibody (PE)

Catalog No. ABIN7867345

The PE-conjugated Human Monoclonal anti-KIR2DL2 (Lirilumab Biosimilar) antibody (ABIN7867345) specifically detects KIR2DL2 (Lirilumab Biosimilar) in FACS. The antibody is reactive with Human samples.

Quick Overview for Recombinant KIR2DL2 (Lirilumab Biosimilar) antibody (PE) (ABIN7867345)

Target: KIR2DL2 (Lirilumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This KIR2DL2 (Lirilumab Biosimilar) antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Product Details anti-KIR2DL2 (Lirilumab Biosimilar) Antibody (PE)

Purpose: PE-conjugated Anti-KIR2DL2(lirilumab biosimilar) mAb

Isotype: IgG4

Application Details

Application Notes: Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid PBS with 0.05 %  Proclin300, 1 % BSA

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment:  Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details for KIR2DL2 (Lirilumab Biosimilar)

Target: KIR2DL2 (Lirilumab Biosimilar)

Alternative Name: lirilumab biosimilar

Target Type: Biosimilar

Background:

Synonyms: CD158b,CD158B1,NKAT-6,NKAT6,p58.2,BMS-986015, IPH2102

Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

UniProt: P43627